192 related articles for article (PubMed ID: 18795795)
1. Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis.
Sikora AL; Frankel BA; Blanchard JS
Biochemistry; 2008 Oct; 47(40):10781-9. PubMed ID: 18795795
[TBL] [Abstract][Full Text] [Related]
2. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
Wang H; Liu L; Hanna PE; Wagner CR
Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
[TBL] [Abstract][Full Text] [Related]
3. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
5. Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Kawamura A; Sandy J; Upton A; Noble M; Sim E
Protein Expr Purif; 2003 Jan; 27(1):75-84. PubMed ID: 12509987
[TBL] [Abstract][Full Text] [Related]
6. Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
Abuhammad AM; Lowe ED; Fullam E; Noble M; Garman EF; Sim E
Protein Cell; 2010 Apr; 1(4):384-392. PubMed ID: 21203950
[TBL] [Abstract][Full Text] [Related]
7. Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.
Westwood IM; Sim E
BMC Biochem; 2007 Mar; 8():3. PubMed ID: 17374145
[TBL] [Abstract][Full Text] [Related]
8. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
9. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
Sandy J; Holton S; Fullam E; Sim E; Noble M
Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E
Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656
[TBL] [Abstract][Full Text] [Related]
11. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
Ramos RM; Perez JM; Baptista LA; de Amorim HL
J Mol Model; 2012 Sep; 18(9):4013-24. PubMed ID: 22460521
[TBL] [Abstract][Full Text] [Related]
12. Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
Abuhammad A; Lowe ED; McDonough MA; Shaw Stewart PD; Kolek SA; Sim E; Garman EF
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1433-46. PubMed ID: 23897467
[TBL] [Abstract][Full Text] [Related]
13. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
14. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
[TBL] [Abstract][Full Text] [Related]
15. NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium.
Delgoda R; Lian LY; Sandy J; Sim E
Biochim Biophys Acta; 2003 Mar; 1620(1-3):8-14. PubMed ID: 12595067
[TBL] [Abstract][Full Text] [Related]
16. Mutational and expression analysis of tbnat and its response to isoniazid.
Sholto-Douglas-Vernon C; Sandy J; Victor TC; Sim E; Helden PD
J Med Microbiol; 2005 Dec; 54(Pt 12):1189-1197. PubMed ID: 16278433
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferases: from structure to function.
Sim E; Walters K; Boukouvala S
Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
Wang X; Yang S; Gu J; Deng J
Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
[TBL] [Abstract][Full Text] [Related]
20. The Mechanism of Acetyl Transfer Catalyzed by Mycobacterium tuberculosis GlmU.
Craggs PD; Mouilleron S; Rejzek M; de Chiara C; Young RJ; Field RA; Argyrou A; de Carvalho LPS
Biochemistry; 2018 Jun; 57(24):3387-3401. PubMed ID: 29684272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
